Form D Explorer

Inspect source fieldsReport a record issue

Form D — Oncocyte Corp

0001493152-25-007952 · filed Feb 24, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$21,743,597
Reported amount sold
$21,743,597
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Oncocyte Corp
CIK
1642380
Entity
Corporation
Jurisdiction
CALIFORNIA
Year incorporated
—
Address
15 CUSHING
IRVINE, California 92618
Phone
(949) 409-7600

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗